Novel Chrysin-De-Allyl PAC-1 Hybrid Analogues as Anticancer Compounds: Design, Synthesis, and Biological Evaluation

被引:9
作者
Al-Oudat, Buthina A. [1 ]
Ramapuram, Hariteja [2 ]
Malla, Saloni [2 ]
Audat, Suaad A. [3 ]
Hussein, Noor [2 ]
Len, Jenna M. [2 ]
Kumari, Shikha [4 ]
Bedi, Mel F. [5 ]
Ashby, Charles R., Jr. [6 ]
Tiwari, Amit K. [2 ]
机构
[1] Jordan Univ Sci & Technol, Dept Med Chem & Pharmacognosy, Fac Pharm, POB 3030, Irbid 22110, Jordan
[2] Univ Toledo, Coll Pharm & Pharmaceut Sci, Dept Pharmacol & Expt Therapeut, Toledo, OH 43614 USA
[3] Jordan Univ Sci & Technol, Coll Sci & Arts, Dept Chem, POB 3030, Irbid 22110, Jordan
[4] Univ Nebraska Med Ctr, Coll Pharm, Dept Pharmaceut Sci, Omaha, NE 68198 USA
[5] Univ Toledo, Coll Pharm & Pharmaceut Sci, Dept Med & Biol Chem, Toledo, OH 43614 USA
[6] St Johns Univ, Coll Pharm & Pharmaceut Sci, Dept Pharmaceut Sci, Queens, NY 11439 USA
关键词
triple-negative breast cancer; cytotoxicity; chrysin analogues; flavonoid; anticancer compounds; ANTITUMOR-ACTIVITY EVALUATION; CASPASE ACTIVATION; INDUCED APOPTOSIS; CANCER; FLAVONOIDS; DERIVATIVES; MECHANISMS; BCL-2; INHIBITION; AGENTS;
D O I
10.3390/molecules25133063
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
New chrysin-De-allyl-Pac-1 hybrid analogues, tethered with variable heterocyclic systems (4a-4o), were rationally designed and synthesized. The target compounds were screened for in vitro antiproliferative efficacy in the triple-negative breast cancer (TNBC) cell line, MDA-MB-231, and normal human mammary epithelial cells (HMECs). Two compounds,4gand4i, had the highest efficacy and selectivity towards MDA-MB-231 cells, and thus, were further evaluated by mechanistic experiments. The results indicated that both compounds4gand4iinduced apoptosis by (1) inducing cell cycle arrest at the G2 phase in MDA-MB-231 cells, and (2) activating the intrinsic apoptotic pathways in a concentration-dependent manner. Physicochemical characterizations of these compounds suggested that they can be further optimized as potential anticancer compounds for TNBC cells. Overall, our results suggest that4gand4icould be suitable leads for developing novel compounds to treat TNBC.
引用
收藏
页数:20
相关论文
共 62 条
[1]   Chrysin, an anti-inflammatory molecule, abrogates renal dysfunction in type 2 diabetic rats [J].
Ahad, Amjid ;
Ganai, Ajaz Ahmad ;
Mujeeb, Mohd ;
Siddiqui, Waseem Ahmad .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 2014, 279 (01) :1-7
[2]   Design, synthesis, and biologic evaluation of novel chrysin derivatives as cytotoxic agents and caspase-3/7 activators [J].
Al-Oudat, Buthina Abdallah ;
Alqudah, Mohammad Ali ;
Audat, Suaad Abdallah ;
Al-Balas, Qosay Ali ;
El-Elimat, Tamam ;
Hassan, Mohammad Abdelhafeez ;
Frhat, Islam Nawaf ;
Azaizeh, Marwah Mohammad .
DRUG DESIGN DEVELOPMENT AND THERAPY, 2019, 13 :423-433
[3]   Novel Thienopyrimidine Derivative, RP-010, Induces β-Catenin Fragmentation and Is Efficacious against Prostate Cancer Cells [J].
Amawi, Haneen ;
Hussein, Noor ;
Boddu, Sai H. S. ;
Karthikeyan, Chandrabose ;
Williams, Frederick E. ;
Ashby, Charles R., Jr. ;
Raman, Dayanidhi ;
Trivedi, Piyush ;
Tiwari, Amit K. .
CANCERS, 2019, 11 (05)
[4]   Polyphenolic Nutrients in Cancer Chemoprevention and Metastasis: Role of the Epithelial-to-Mesenchymal (EMT) Pathway [J].
Amawi, Haneen ;
Ashby, Charles R., Jr. ;
Samuel, Temesgen ;
Peraman, Ramalingam ;
Tiwari, Amit K. .
NUTRIENTS, 2017, 9 (08)
[5]   Thienopyrimidine derivatives exert their anticancer efficacy via apoptosis induction, oxidative stress and mitotic catastrophe [J].
Amawi, Haneen ;
Karthikeyan, Chandrabose ;
Pathak, Rekha ;
Hussein, Noor. ;
Christman, Ryann ;
Robey, Robert ;
Ashby, Charles R., Jr. ;
Trivedi, Piyush ;
Malhotra, Ashim ;
Tiwari, Amit K. .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2017, 138 :1053-1065
[6]   HM015k, a Novel Silybin Derivative, Multi-Targets Metastatic Ovarian Cancer Cells and Is Safe in Zebrafish Toxicity Studies [J].
Amawi, Haneen ;
Hussein, Noor A. ;
Karthikeyan, Chandrabose ;
Manivannan, Elangovan ;
Wisner, Alexander ;
Williams, Frederick E. ;
Samuel, Temesgen ;
Trivedi, Piyush ;
Ashby, Charles R., Jr. ;
Tiwari, Amit K. .
FRONTIERS IN PHARMACOLOGY, 2017, 8
[7]   Cancer chemoprevention through dietary flavonoids: what's limiting? [J].
Amawi, Haneen ;
Ashby, Charles R., Jr. ;
Tiwari, Amit K. .
CHINESE JOURNAL OF CANCER, 2017, 36
[8]   Design, synthesis and in vitro cell-based evaluation of the anti-cancer activities of hispolon analogs [J].
Balaji, Neduri V. ;
Ramani, Modukuri V. ;
Viana, Arabela G. ;
Sanglard, Leticia P. ;
White, Jason ;
Mulabagal, Vanisree ;
Lee, Crystal ;
Gana, Theophilus J. ;
Egiebor, Nosa O. ;
Subbaraju, Gottumukkala V. ;
Tiwari, Amit K. .
BIOORGANIC & MEDICINAL CHEMISTRY, 2015, 23 (09) :2148-2158
[9]  
Beecher GR, 2003, J NUTR, V133, p3248S
[10]   Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease [J].
Bianchini, Giampaolo ;
Balko, Justin M. ;
Mayer, Ingrid A. ;
Sanders, Melinda E. ;
Gianni, Luca .
NATURE REVIEWS CLINICAL ONCOLOGY, 2016, 13 (11) :674-690